BAM
WINT

Brave Asset Management’s Windtree Therapeutics Inc WINT Stock Holding History

Brave Asset Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-748
Closed -$2K – 382
2016
Q3 		$2K Hold
748
– – ﹤0.01% 375
2016
Q2 		$1K Sell
748
-1,570
-68% -$3.79K ﹤0.01% 394
2016
Q1 		$4K Sell
2,318
-3
-0.1% -$6 ﹤0.01% 394
2015
Q4 		$7K Hold
2,321
– – ﹤0.01% 380
2015
Q3 		$10K Sell
2,321
-643
-22% -$4.26K 0.01% 347
2015
Q2 		$28K Hold
2,964
– – 0.02% 285
2015
Q1 		$49K Hold
2,964
– – 0.03% 226
2014
Q4 		$48K Sell
2,964
-143
-5% -$3.14K 0.03% 229
2014
Q3 		$80K Hold
3,107
– – 0.06% 188
2014
Q2 		$77K Buy
3,107
+239
+8% +$6.11K 0.05% 192
2014
Q1 		$86K Sell
2,868
-286
-9% -$9.62K 0.07% 175
2013
Q4 		$99K Buy
+3,154
New +$98.6K 0.08% 167

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Brave Asset Management's WINT Position: Q4 2016 in Review

Brave Asset Management sold out of Windtree Therapeutics Inc (WINT) in Q4 2016, closing a stake of 748 shares — an estimated $2K sold.

Brave Asset Management first reported a position in WINT in Q4 2013 and held it in 12 quarters. The position peaked at $99K in Q4 2013. 31 funds tracked by Wall St. Rank hold WINT as of Q4 2016.

  • Brave Asset Management reported no remaining Windtree Therapeutics Inc position as of Q4 2016 after selling out during the quarter.
  • Brave Asset Management sold 748 Windtree Therapeutics Inc shares in Q4 2016, an estimated $2K.
  • Brave Asset Management first reported a position in Windtree Therapeutics Inc in Q4 2013 and held it in 12 quarters.
  • Brave Asset Management's Windtree Therapeutics Inc position peaked at $99K in Q4 2013.
  • 31 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2016.

Based on Brave Asset Management's 13F filing for Q4 2016, filed 27 Jan 2017.